3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
7
Breast Neoplasms
7
Prostatic Neoplasms
6
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Smoking Cessation
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Interventions
Ifosfamide
12
Filgrastim
12
Carboplatin
12
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Paclitaxel
9
Cyclophosphamide
7
Cisplatin
6
Thiotepa
4
Flow Cytometry
4
Radiotherapy
3
Immunologic Techniques
3
pegfilgrastim
2
etoposide phosphate
2
Vinblastine
2
Temozolomide
2
Microarray Analysis
2
Methylprednisolone
2
Busulfan
2
Alemtuzumab
2
guadecitabine
1
fludarabine phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Topotecan
1
Tacrolimus
1
Sunitinib
1
Psychiatric Rehabilitation
1
Prednisone
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Testicular Germ Cell Tumor
×
Hematologic Tests
×
Clear all
NCT02109926
2018-05-11
TESTIS
Centre Leon Berard
Completed
1,367 enrolled